Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Beauty Health (SKIN) Asset Writedowns and Impairment (2020 - 2025)

Beauty Health (SKIN) has disclosed Asset Writedowns and Impairment for 6 consecutive years, with -$545000.0 as the latest value for Q3 2025.

  • On a quarterly basis, Asset Writedowns and Impairment fell 102.64% to -$545000.0 in Q3 2025 year-over-year; TTM through Sep 2025 was $7.2 million, a 75.13% decrease, with the full-year FY2024 number at $28.0 million, up 53.24% from a year prior.
  • Asset Writedowns and Impairment was -$545000.0 for Q3 2025 at Beauty Health, down from $1.7 million in the prior quarter.
  • In the past five years, Asset Writedowns and Impairment ranged from a high of $20.7 million in Q3 2024 to a low of -$2.0 million in Q2 2023.
  • A 5-year average of $2.9 million and a median of $739000.0 in 2025 define the central range for Asset Writedowns and Impairment.
  • Biggest YoY gain for Asset Writedowns and Impairment was 1357.21% in 2023; the steepest drop was 1050.0% in 2023.
  • Beauty Health's Asset Writedowns and Impairment stood at $342000.0 in 2021, then soared by 915.79% to $3.5 million in 2022, then surged by 83.28% to $6.4 million in 2023, then dropped by 16.82% to $5.3 million in 2024, then tumbled by 110.29% to -$545000.0 in 2025.
  • Per Business Quant, the three most recent readings for SKIN's Asset Writedowns and Impairment are -$545000.0 (Q3 2025), $1.7 million (Q2 2025), and $739000.0 (Q1 2025).